| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $15.0B | $11.1B | $8.4B | $9.6B | $6.8B | $2.8B | $1.1B | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $0.3B | $0.2B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| Operating Income | $1.3B | $4.4B | $4.6B | $6.5B | $4.0B | $-5.5B | $-0.4B | $0.2B |
| Net Income | $1.7B | $3.3B | $3.1B | $4.4B | $2.2B | $-4.5B | $-0.5B | $0.3B |
| EPS (Basic) | $5.73 | $15.53 | $17.34 | $24.61 | $12.35 | $-28.59 | $-3.04 | $2.50 |
| EPS (Diluted) | $5.73 | $15.53 | $17.34 | $24.61 | $12.30 | $-28.59 | $-3.04 | $2.50 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $71.1B | $67.3B | $29.0B | $26.2B | $22.9B | $17.6B | $23.5B | $21.6B |
| Current Assets | $1.9B | $2.1B | $1.6B | $1.4B | $1.4B | $0.6B | $0.9B | $0.9B |
| Cash & Equivalents | $0.1B | $0.2B | $0.6B | $0.2B | $0.7B | $0.1B | $0.1B | $0.2B |
| Total Liabilities | $28.1B | $27.4B | $11.6B | $10.5B | $9.7B | $7.8B | $8.6B | $7.4B |
| Current Liabilities | $4.6B | $4.8B | $2.1B | $1.7B | $1.4B | $1.2B | $1.3B | $1.0B |
| Stockholders' Equity | $37.0B | $37.7B | $16.6B | $15.0B | $12.1B | $8.8B | $13.2B | $13.7B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $8.8B | $6.4B | $5.9B | $6.3B | $3.9B | $2.1B | $2.7B | — |
| Investing Cash Flow | $-7.8B | $-11.2B | $-3.3B | $-3.3B | $-1.5B | $-2.1B | $-3.9B | — |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-1.0B | $4.4B | $-2.2B | $-3.5B | $-1.8B | $-0.0B | $1.1B | — |